RI
APYX icon

RTW Investments’s Apyx Medical APYX Stock Holding History

RTW Investments’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,025,963
Closed -$2.69M – 71
2023
Q4 		$2.69M Sell
1,025,963
-751,231
-42% -$1.82M 0.04% 60
2023
Q3 		$5.69M Hold
1,777,194
– – 0.12% 56
2023
Q2 		$8.94M Sell
1,777,194
-1,621,085
-48% -$8.21M 0.17% 52
2023
Q1 		$9.79M Hold
3,398,279
– – 0.2% 45
2022
Q4 		$7.95M Hold
3,398,279
– – 0.16% 51
2022
Q3 		$15.3M Hold
3,398,279
– – 0.35% 44
2022
Q2 		$19.9M Hold
3,398,279
– – 0.51% 43
2022
Q1 		$22.2M Hold
3,398,279
– – 0.46% 50
2021
Q4 		$43.6M Hold
3,398,279
– – 0.64% 49
2021
Q3 		$47.1M Buy
3,398,279
+7,000
+0.2% +$73.6K 0.71% 39
2021
Q2 		$35M Hold
3,391,279
– – 0.53% 48
2021
Q1 		$32.8M Hold
3,391,279
– – 0.51% 52
2020
Q4 		$24.4M Hold
3,391,279
– – 0.41% 52
2020
Q3 		$16M Hold
3,391,279
– – 0.38% 56
2020
Q2 		$18.8M Hold
3,391,279
– – 0.53% 41
2020
Q1 		$12.2M Hold
3,391,279
– – 0.52% 39
2019
Q4 		$28.7M Buy
3,391,279
+21,000
+0.6% +$152K 1.08% 24
2019
Q3 		$22.8M Sell
3,370,279
-29,620
-0.9% -$210K 1.36% 22
2019
Q2 		$22.8M Buy
3,399,899
+275,000
+9% +$1.49M 1.22% 24
2019
Q1 		$19.7M Buy
3,124,899
+733,001
+31% +$5.67M 1.35% 25
2018
Q4 		$15.5M Buy
2,391,898
+156,351
+7% +$947K 1.42% 22
2018
Q3 		$15.9M Buy
2,235,547
+153,410
+7% +$853K 0.95% 25
2018
Q2 		$9.06M Buy
2,082,137
+150,189
+8% +$554K 0.65% 25
2018
Q1 		$5.74M Buy
1,931,948
+179,337
+10% +$462K 0.55% 26
2017
Q4 		$4.56M Buy
1,752,611
+613,011
+54% +$1.91M 0.76% 27
2017
Q3 		$3.85M Buy
+1,139,600
New +$2.94M 0.67% 23

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $1.02B AUM 28.26% 1-Year Est. Return

RTW Investments's APYX Position: Q1 2024 in Review

RTW Investments sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 1,025,963 shares — an estimated $2.69M sold.

RTW Investments first reported a position in APYX in Q3 2017 and held it in 26 quarters. The position peaked at $47.1M in Q3 2021. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • RTW Investments reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • RTW Investments sold 1,025,963 Apyx Medical shares in Q1 2024, an estimated $2.69M.
  • RTW Investments first reported a position in Apyx Medical in Q3 2017 and held it in 26 quarters.
  • RTW Investments's Apyx Medical position peaked at $47.1M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on RTW Investments's 13F filing for Q1 2024, filed 15 May 2024.